NASDAQ : LITS

Lite Strategy, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 1.17 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 35.58M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Details

NameLite Strategy, Inc.
SectorHealthcare
IndustryBiotechnology
Employees5
Founded2000
CeoJustin File
CountryUnited States
ExchangeNASDAQ
Fiscal YearJuly - June
Reporting CurrencyUSD
IsinUS55279B3015
Cusip55279B301
Cik0001262104
Stock TypeCommon Stock

Key executives

NameTitle
Justin J. File C.P.A.Chief Executive Officer, Chief Financial Officer, Corporate Secretary and Director
Anne FreseChief People Officer
Dr. Robert D. Mass M.D.Strategic Advisor

Contact

Address9920 Pacific Heights Blvd., Suite 150, San Diego, California 92121, United States
Phone858 369 7100
Websitehttps://www.litestrategy.com